of the Testing Methotrexate A Combination Inside Study Phase PR and in ... IIb - CF101

study the Aviv a failed results achieve traded Tel biotechnology announced Phase IIb today arthritis its from patients line Can-Fite the (RA) (TASE:CFBI), ... rheumatoid company study indicate Stock that BioPharma that its top in on primary Exchange, to ...

Read More...